Bookmark and Share

Compound Summary for: CID 25126798

INCB018424

Also known as: Ruxolitinib, 941678-49-5, INCB-018424, UNII-82S8X8XX8H, CHEBI:66919, Ruxolitinib, 941678-49-5, INCB 018424
Molecular Formula: C17H18N6   Molecular Weight: 306.36502   InChIKey: HFNKQEVNSGCOJV-OAHLLOKOSA-N
Ruxolitinib is a janus-associated kinase inhibitor indicated to treat bone marrow cancer, specifically intermediate or high-risk myelofibrosis. FDA approved on November 16, 2011.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _